CNBC 快讯 5月12日 11:05 Hims & Hers财报暴雷：GLP-1渠道故事被现实打脸，数字健康板块风险溢价重估 Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform. FG 100 读报告 →